<?xml version="1.0" encoding="UTF-8"?>
<p>The coronavirus 3CL
 <sup>pro</sup> employs conserved cysteine and histidine residues, which serve as the principal nucleophile and general acid–base catalyst, respectively, at its catalytic site [
 <xref rid="B9-viruses-12-00240" ref-type="bibr">9</xref>,
 <xref rid="B10-viruses-12-00240" ref-type="bibr">10</xref>,
 <xref rid="B31-viruses-12-00240" ref-type="bibr">31</xref>]. 3CL
 <sup>pro</sup> recognizes a conserved cleavage site containing a hydrophobic residue (preferably L) at the P2 position, a Q at the P1 position, and a small aliphatic amino acid residue (S, G or A) at the P1′ position [
 <xref rid="B10-viruses-12-00240" ref-type="bibr">10</xref>,
 <xref rid="B32-viruses-12-00240" ref-type="bibr">32</xref>,
 <xref rid="B33-viruses-12-00240" ref-type="bibr">33</xref>]. Research breakthroughs in 3CL
 <sup>pro</sup> structures have made it possible to design specific inhibitors against coronavirus replication, and some of these inhibitors show excellent broad-spectrum anti-coronavirus effects [
 <xref rid="B17-viruses-12-00240" ref-type="bibr">17</xref>,
 <xref rid="B23-viruses-12-00240" ref-type="bibr">23</xref>,
 <xref rid="B25-viruses-12-00240" ref-type="bibr">25</xref>,
 <xref rid="B26-viruses-12-00240" ref-type="bibr">26</xref>,
 <xref rid="B31-viruses-12-00240" ref-type="bibr">31</xref>,
 <xref rid="B34-viruses-12-00240" ref-type="bibr">34</xref>,
 <xref rid="B35-viruses-12-00240" ref-type="bibr">35</xref>]. GC376, a dipeptidyl bisulfite adduct salt, exerts an excellent inhibitory effect on some picornaviruses and coronaviruses in enzymatic or cell-based assays [
 <xref rid="B35-viruses-12-00240" ref-type="bibr">35</xref>,
 <xref rid="B36-viruses-12-00240" ref-type="bibr">36</xref>,
 <xref rid="B37-viruses-12-00240" ref-type="bibr">37</xref>]. Notably, antiviral treatment with GC376 leads to a full recovery in laboratory cats with feline infectious peritonitis (FIP), a highly fatal feline disease caused by feline coronavirus (FIPV) that has no commercial vaccines or drugs [
 <xref rid="B18-viruses-12-00240" ref-type="bibr">18</xref>]. In addition, PEDV 3CL
 <sup>pro</sup> shares a 62% sequence identity with FIPV 3CL
 <sup>pro</sup>.
</p>
